$AMBQ

ZHANG KER sold $11K of AMBQ

ZHANG KER sold 185 shares of Ambiq Micro, Inc. (AMBQ) at $56.92 on 2026-09-04.

Original reporting
SEC EDGAR · ZHANG KER
Published Sep 9, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMBQ
Neutral
low confidence
Mentioned
$AMBQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQNeutralLow
01

Why it matters

The sale represents a routine liquidity event with limited market impact.

02

Market read

The filing provides a small, new data point but is unlikely to move the stock or sector.

03

What to watch

The director still holds a sizable stake (30,366 shares), indicating continued confidence.

Relevance 3/10Novelty 3/10Timing: post‑market on Sep 4, 2026

Background

SEC Form 4 filings disclose insider transactions. Ambiq Micro (NASDAQ: AMBQ) is a micro‑cap semiconductor company.

Company-level read

Ticker impact

$AMBQNeutralLow confidence
Context

Director Zhang Ker sold 185 shares of Ambiq Micro for $10,530, reducing his stake to 30,366 shares.

Expected impact

No material price move expected; at most a slight short‑term dip.

Evidence & confidence

The transaction size is small relative to market cap and does not signal a change in outlook.

Market effects

No broader sector impact; insider activity is isolated to Ambiq Micro.

None; the filing is a routine US disclosure.

Minimal; does not affect global markets.

Counterpoint

Some investors may view any insider sale as a bearish signal, but the amount is too trivial to warrant a position change.

Key entities

  • Ambiq Micro, Inc.

    US‑listed semiconductor firm (NASDAQ: AMBQ).

  • Zhang Ker

    Director of Ambiq Micro who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.